| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/AJCP/AQV087 |
| P698 | PubMed publication ID | 27124906 |
| P2093 | author name string | Xiaohui Zhao | |
| Ronald Kim | |||
| Kambiz Nael | |||
| William Wu | |||
| Ali Nael | |||
| Sherif Rezk | |||
| Vighnesh Walavalkar | |||
| P2860 | cites work | Microbial translocation is a cause of systemic immune activation in chronic HIV infection | Q22251054 |
| Human herpesvirus 8-unrelated primary effusion lymphoma-like lymphoma: report of a rare case and review of 54 cases in the literature | Q27022041 | ||
| Epstein-Barr virus-driven lymphomagenesis in the context of human immunodeficiency virus type 1 infection | Q27022706 | ||
| Primary central nervous system post-transplantation lymphoproliferative disorder: an International Primary Central Nervous System Lymphoma Collaborative Group Report | Q30411688 | ||
| HIV patients developing primary CNS lymphoma lack EBV-specific CD4+ T cell function irrespective of absolute CD4+ T cell counts | Q33280133 | ||
| The changing incidence of primary central nervous system lymphoma is driven primarily by the changing incidence in young and middle-aged men and differs from time trends in systemic diffuse large B-cell non-Hodgkin's lymphoma | Q33608166 | ||
| Primary Central Nervous System T-Cell Lymphoma in Aids Patients: Case Report and Literature Review | Q33727927 | ||
| Opposite effects of HIV-1 p17 variants on PTEN activation and cell growth in B cells | Q33851786 | ||
| Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study | Q34059657 | ||
| Pathology of AIDS-related lymphomas and other AIDS-defining neoplasms | Q34291996 | ||
| Epstein-Barr virus | Q34556276 | ||
| Cumulative incidence of cancer among individuals with acquired immunodeficiency syndrome in the United States | Q34643410 | ||
| Epstein-Barr virus-associated lymphoproliferative disorders. | Q34654750 | ||
| Immunologic and virologic predictors of AIDS-related non-hodgkin lymphoma in the highly active antiretroviral therapy era. | Q34806379 | ||
| Epstein-barr virus, the immune system, and associated diseases | Q35029255 | ||
| B-cell stimulatory cytokines and markers of immune activation are elevated several years prior to the diagnosis of systemic AIDS-associated non-Hodgkin B-cell lymphoma. | Q35093835 | ||
| Epstein-Barr virus type 2 latently infects T cells, inducing an atypical activation characterized by expression of lymphotactic cytokines. | Q35115666 | ||
| Latent membrane protein 1 of Epstein-Barr virus activates the hTERT promoter and enhances telomerase activity in B lymphocytes | Q36933913 | ||
| Factors associated with survival among patients with AIDS-related primary central nervous system lymphoma | Q37666176 | ||
| The management of primary central nervous system lymphoma related to AIDS in the HAART era. | Q37938530 | ||
| Primary central nervous system lymphoma: is there still a role for radiotherapy? | Q37941995 | ||
| HIV-related hematological malignancies: a concise review | Q38285272 | ||
| hTERT inhibition triggers Epstein-Barr virus lytic cycle and apoptosis in immortalized and transformed B cells: a basis for new therapies | Q39187962 | ||
| CNK/T-cell brain lymphoma associated with Epstein-Barr virus in a patient with AIDS. | Q40438133 | ||
| HIV-Associated Hodgkin's Lymphoma: Prognosis and Therapy in the Era of cART. | Q40512007 | ||
| Hodgkin lymphoma is as common as non-Hodgkin lymphoma in HIV-positive patients with sustained viral suppression and limited immune deficiency: a prospective cohort study | Q41727813 | ||
| Markers of microbial translocation and risk of AIDS-related lymphoma | Q43952336 | ||
| Prognostic factors in patients with HIV-associated peripheral T-cell lymphoma: a multicenter study | Q44051292 | ||
| High-dose methotrexate based chemotherapy with deferred radiation for treatment of newly diagnosed primary central nervous system lymphoma | Q44757769 | ||
| Epstein-Barr virus load and immune activation in human immunodeficiency virus type 1-infected patients | Q45182657 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | central nervous system lymphoma | Q136312 |
| primary central nervous system lymphoma | Q3246818 | ||
| P304 | page(s) | 258-265 | |
| P577 | publication date | 2016-02-01 | |
| P1433 | published in | American Journal of Clinical Pathology | Q15750224 |
| P1476 | title | CD4-Positive T-Cell Primary Central Nervous System Lymphoma in an HIV Positive Patient | |
| P478 | volume | 145 |
| Q48599001 | Comparative study of CD4 and CD45RO T cells and CD20 B cells in cerebrospinal fluid of syphilitic meningitis and tuberculous meningitis patients |
| Q50948891 | MiR-30a increases MDSC differentiation and immunosuppressive function by targeting SOCS3 in mice with B-cell lymphoma. |
| Q57058193 | Primary Peripheral Gamma Delta T-Cell Lymphoma of the Central Nervous System: Report of a Case Involving the Intramedullary Spinal Cord and Presenting with Myelopathy |
Search more.